We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Paxlovid is an oral SARS-CoV-2 main protease (Mpro) inhibitor therapy, containing 300mg nirmatrelvir and 100mg ritonavir at a standard dose, prescribed early after infection to help prevent potential severe Covid-19 in adult patients
Fruquintinib is said to be a highly selective and potent inhibitor of
BenchSci’s ASCEND platform supports researchers to discover biological connections, lowering the trial-and-error
The facility now offers storage, kitting, and distribution of advanced therapies for
The fast track status for the investigational, oral factor XIa (FXIa) inhibitor
